Form 4: RTW Investments Amends Convertible Note in Allurion Technologies, Acquiring Significant Stake

RTW Investments, LP, along with affiliated funds, acquired a significant stake in Allurion Technologies through the conversion of convertible notes and other transactions, as detailed in a recent SEC Form 4 filing.

Summary

• RTW Investments, LP, along with related entities like RTW Master Fund, Ltd. and RTW Innovation Master Fund, Ltd., filed a Form 4 with the SEC.
• The filing reports changes in beneficial ownership of Allurion Technologies, Inc. (ALUR) stock.
• On April 16, 2025, the conversion price of $5.0 million aggregate principal amount of convertible senior secured notes held by the Reporting Persons (the 'Notes') was amended from $40.50 per share to $3.35 per share.
• RTW Investments acquired 822,722 shares of common stock at $3.35 per share through conversion.
• RTW Innovation acquired 631,954 shares of common stock at $3.35 per share through conversion.
• RTW Funds acquired 37,863 shares of common stock at $3.35 per share through conversion.
• Following these transactions, RTW Investments indirectly owns 1,324,532 shares, RTW Innovation indirectly owns 1,027,287 shares, and RTW Funds indirectly owns 164,233 shares.
• The filing also details the acquisition and disposal of convertible notes with a face value of $5,000,000, convertible into 1,492,539 shares of common stock.
• Roderick Wong, M.D., is the Managing Partner and Chief Investment Officer of RTW Investments, LP.
• RTW Investments has the right to designate two members of Allurion Technologies' board of directors.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. RTW Investments is increasing its stake in Allurion, which suggests confidence. However, the dilution of existing shares is a potential concern.

Positives

• RTW Investments' increased stake could signal confidence in Allurion Technologies' future prospects.
• The amended conversion price allows for a more favorable conversion rate for RTW Investments.
• RTW Investments' board representation provides them with influence over Allurion's strategic direction.

Negatives

• The conversion of notes dilutes existing shareholders' equity.
• The potential for further note conversions could create downward pressure on the stock price.
• The 9.99% ownership limit on note conversions (unless discretionary) may restrict RTW Funds' ability to fully convert their holdings.

Risks

• The market's reaction to the increased ownership by RTW Investments is uncertain.
• Future conversions of the remaining notes could further dilute existing shareholders.
• The performance of Allurion Technologies will directly impact the value of RTW Investments' stake.

Future Outlook

The document does not explicitly provide a future outlook, but the note conversion suggests a continued investment and involvement by RTW Investments in Allurion Technologies.

Management Comments

• Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of the Adviser.
• Each Reporting Person disclaims beneficial ownership of the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Industry Context

This announcement reflects ongoing investment activity within the medical technology sector, where convertible notes are a common financing tool. Institutional investors like RTW Investments often take significant stakes in companies with promising technologies.

Comparison to Industry Standards

• Convertible notes are a common financing mechanism in the biotech and medical device industries, similar to financings seen with companies like Adaptimmune Therapeutics and CRISPR Therapeutics.
• The 6% interest rate on the convertible notes is within the typical range for such instruments in the current market environment.
• The conversion price adjustment from $40.50 to $3.35 suggests a significant change in the perceived value or risk profile of Allurion Technologies, potentially aligning with industry trends or company-specific developments.

Stakeholder Impact

• Shareholders may experience dilution due to the conversion of notes.
• Employees may be impacted by strategic decisions influenced by RTW Investments' board representatives.
• Customers may see changes in product development or service offerings based on the company's strategic direction.

Next Steps

• Potential further conversions of the remaining convertible notes.
• Continued monitoring of Allurion Technologies' performance by RTW Investments.
• RTW Investments' representatives on the board will likely influence strategic decisions.

Key Dates

Keywords

Allurion Technologies, RTW Investments, Convertible Note, Beneficial Ownership, SEC Form 4, ALUR, Stake, Conversion